GLP-1 Drugs and Kidney Disease - The Trial That Changed Everything

GLP-1 Drugs and Kidney Disease - Discover the breakthrough science with Julia Cartwright

Join host Julia Cartwright as she uncovers the surprising kidney-protecting powers of GLP-1 drugs—those medications you know for blood sugar control and weight loss. Through groundbreaking trial data and expert insights, discover how these drugs shield kidney tissue, who benefits most, and the critical access gaps leaving patients behind. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

GLP-1 Drugs and Kidney Disease - Who Benefits Most and Who's Being Left Behind

Host Julia Cartwright examines who benefits most from GLP-1 drugs for kidney protection in type 2 diabetes and chronic kidney disease. Drawing on the FLOW trial, Lancet meta-analyses, and Vanderbilt genetic research, she explores prescription gaps preventing high-risk patients from accessing these therapies and discusses emerging evidence for non-diabetic populations with obesity-related kidney disease. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

GLP-1 Drugs and Kidney Disease - How a Diabetes Drug Learned to Protect Your Kidneys

Join host Julia Cartwright as she explores how GLP-1 drugs like semaglutide—originally designed for diabetes—became powerful kidney protectors. Through clinical trials and genetic studies, Julia unpacks the dual-channel protection these medications offer: systemic effects like blood sugar control and direct tissue-level defense against fibrosis and inflammation. Discover why this discovery is reshaping kidney disease treatment. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

GLP-1 Drugs and Kidney Disease - The Trial That Changed Everything

Julia Cartwright examines how the groundbreaking FLOW trial revealed GLP-1 drugs like semaglutide reduce chronic kidney disease progression by 24% in diabetic patients—a finding so significant the study was stopped early, reshaping treatment for millions facing kidney failure. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.